Nordic Life Science 1
What the Pipeline Report reveals about strengths
and weaknesses of Swedish life science SWEDENBIO RECENTLY RELEASED our new Swedish Drug Discovery and Development Pipeline Report 2026 at NLSDays in Gothenburg. This fourteenth edition once again shows that Swedish drug development remains on a stable trajectory. Fluctations in the number of drug-developing companies and in the number or type of projects are minimal compared to our report from three years ago. 86 | NORDICLIFESCIENCE.ORG R&D // COLUMN